EUVIMEDEUVIMED entdecken
Editorial

Isavuconazole as an alternative for antifungal prophylaxis in patients with hematological malignancies: Is the signal sufficient to support clinical practice?

Armelle Perez-Cortes Villalobos, Eric J Bow

Transplant Infectious Disease · 2023

DOI: 10.1111/tid.14046 ↗

Kurz gefasst

Editorial in der Zeitschrift Transplant Infectious Disease, 2023. Verfasst von Armelle Perez-Cortes Villalobos und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology and Infectious Diseases, Max Rady School of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada. Hauptthemen laut MEDLINE: Antifungal Agents, Hematologic Neoplasms. Die Arbeit nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antifungal AgentsHematologic NeoplasmsHumansTriazolesNitrilesPyridines

Substanzen

Antifungal AgentsTriazolesNitrilesisavuconazolePyridines

Autor:innen und Institutionen

  • Department of Medical Microbiology and Infectious Diseases, Max Rady School of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.
  • Section of Infectious Diseases, Department of Internal Medicine, Max Rady School of Medicine, The University of Manitoba, Winnipeg, Manitoba, Canada.
  • Section of Haematology/Oncology, Department of Internal Medicine, Max Rady School of Medicine, The University of Manitoba, Winnipeg, Manitoba, Canada.
  • Department of Medical Oncology and Haematology, CancerCare Manitoba, Winnipeg, Manitoba, Canada.
  • Infection Control Services, CancerCare Manitoba, Winnipeg, Manitoba, Canada.

Zitieren

APA

Villalobos, A. P., & Bow, E. J. (2023). Isavuconazole as an alternative for antifungal prophylaxis in patients with hematological malignancies: Is the signal sufficient to support clinical practice?. Transplant Infectious Disease. https://doi.org/10.1111/tid.14046

Vancouver

Villalobos AP, Bow EJ. Isavuconazole as an alternative for antifungal prophylaxis in patients with hematological malignancies: Is the signal sufficient to support clinical practice?. Transplant Infectious Disease. 2023. doi:10.1111/tid.14046

BibTeX
@article{Villalobos2023,
  author = {Villalobos, Armelle Perez-Cortes and Bow, Eric J},
  title = {Isavuconazole as an alternative for antifungal prophylaxis in patients with hematological malignancies: Is the signal sufficient to support clinical practice?},
  journal = {Transplant Infectious Disease},
  year = {2023},
  doi = {10.1111/tid.14046}
}
Kostenlos starten →